CEDAR KNOLLS, N.J., Sept. 10, 2019 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition made from fertilized egg yolk that helps build lean muscle, has entered into a research agreement with the Department of Kinesiology at

CAMBRIDGE, Mass., Sept. 10, 2019 /PRNewswire/ -- The International Biocodex Microbiota Foundation has awarded its 2019 grant to Emily Balskus, Professor of Chemistry and Chemical Biology at Harvard University. "I am extremely honored to be chosen to receive this grant and am very grateful to the Biocodex

WILLIAMSTOWN, Mass., Sept. 10, 2019 /PRNewswire/ -- Talkspace, the global leader in telebehavioral health, today announces its first higher educational institution partnership with Williams College.

ROCKLAND, Mass., Sept. 10, 2019 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the initiation of two global pivotal Phase III trials (

SAN DIEGO, Sept. 10, 2019 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of

PORTLAND, Ore., Sept. 10, 2019 /PRNewswire/ -- Social CBD (www.thesocialcbd.com), the wellness company providing the highest-quality, lab-tested and certified CB

TORRANCE, Calif., Sept. 10, 2019 /PRNewswire/ -- Emmaus Life Sciences, Inc. (Nasdaq: EMMA), a leader in sickle cell disease treatment, announced today that it was informed yesterday that the Nasdaq Hearings Panel had declined to reverse the Nasdaq Listing Qualification's decision to delist Emmaus common stock and warrants. As a result, Em

NEW YORK, Sept. 10, 2019 /PRNewswire/ -- Today, Senior Helpers®, the nation's premier provider of in-home senior care, announced that it has begun deploying the industr

LAKE FOREST, Calif., Sept. 10, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq:INMD) ("InMode"), a leading global provider of innovative medical technologies, hosted over 600 physicians and medical professionals at its Inaugural North American User Meeting, titled the "Insider Summit," in August 2019 in Nashville, Ten

HOUSTON, Sept. 10, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that it has selected Clear Dermatology & Aesthet